Quarterly Results • Search Archive

Suven Life Sciences Limited
Results, Financials & Updates

Follow Suven Life Sciences Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

1 published deep dive 1 quarter 1 sector

Company Overview

Suven Life Sciences Limited: latest results and financials

Latest covered quarterQ1 FY27NSE: SUVEN
Revenue from operations₹3.57 CrReported in the latest covered quarter
Profit after tax₹-127.61 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Suven Life Sciences Limited is a biopharmaceutical company engaged in drug discovery and the development of New Chemical Entities (NCEs) targeting central nervous system (CNS) disorders with high unmet medical needs globally. The company operates on a consolidated basis with its wholly owned Delaware subsidiary, Suven Neurosciences, Inc., which handles clinical development programs in international markets.

← All quarterly results

Quarter history

Suven Life Sciences Limited Results & Financials

Latest Nivata coverage: Q1 FY27 · revenue ₹3.57 Cr · PAT ₹-127.61 Cr.

Nivata currently has one covered quarter for this company. This page remains the stable company-results hub and expands automatically as additional quarters are published.